SKIV2L2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.435200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.521400E-01
Normal-vs-Stage2
7.828400E-01
Normal-vs-Stage3
7.408500E-02
Normal-vs-Stage4
4.970200E-01
Stage1-vs-Stage2
3.239000E-01
Stage1-vs-Stage3
1.263410E-01
Stage1-vs-Stage4
7.662200E-01
Stage2-vs-Stage3
1.443180E-01
Stage2-vs-Stage4
2.031800E-01
Stage3-vs-Stage4
4.640400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.246400E-01
Normal-vs-AfricanAmerican
6.995800E-01
Normal-vs-Asian
6.244000E-01
Caucasian-vs-AfricanAmerican
2.872000E-01
Caucasian-vs-Asian
4.879000E-01
AfricanAmerican-vs-Asian
2.850600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.757200E-01
Normal-vs-Female
9.174200E-01
Male-vs-Female
5.657400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.567200E-01
Normal-vs-Age(41-60Yrs)
8.738600E-01
Normal-vs-Age(61-80Yrs)
6.351000E-01
Normal-vs-Age(81-100Yrs)
8.042800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.683400E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.857600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.745200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.669900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.496400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.166800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.072000E-01
Normal-vs-Daily Drinker
5.149800E-01
Normal-vs-Weekly Drinker
5.674400E-01
Normal-vs-Occasional Drinker
7.439200E-01
Normal-vs-Social Drinker
8.370800E-01
Non Drinker-vs-Daily Drinker
8.017800E-01
Non Drinker-vs-Weekly Drinker
7.503400E-01
Non Drinker-vs-Occasional Drinker
5.324300E-02
Non Drinker-vs-Social Drinker
3.833000E-01
Daily Drinker-vs-Weekly Drinker
9.223800E-01
Daily Drinker-vs-Occasional Drinker
6.706000E-02
Daily Drinker-vs-Social Drinker
3.496000E-01
Weekly Drinker-vs-Occasional Drinker
1.153790E-01
Weekly Drinker-vs-Social Drinker
3.943000E-01
Occasional Drinker-vs-Social Drinker
3.519000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.367600E-02
Normal-vs-Grade 2
2.030400E-02
Normal-vs-Grade 3
7.282200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.923600E-01
Grade 1-vs-Grade 3
2.210400E-01
Grade 1-vs-Grade 4
9.367600E-02
Grade 2-vs-Grade 3
7.596000E-01
Grade 2-vs-Grade 4
2.030400E-02
Grade 3-vs-Grade 4
7.282200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.505000E-01
Normal-vs-NonDiabetic
6.471000E-01
Diabetic-vs-NonDiabetic
9.293000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.045600E-01
Normal-vs-NoPancreatitis
7.312400E-01
Pancreatitis-vs-NoPancreatitis
3.880800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.862600E-01
Normal-vs-N1
7.714400E-01
N0-vs-N1
3.819400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.997400E-01
Normal-vs-TP53-NonMutant
6.955800E-01
TP53-Mutant-vs-TP53-NonMutant
4.416800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
